Skip to main content

Elanco Animal Health Incorporated (ELAN)

New York Stock Exchange Healthcare Drug Manufacturers - Specialty & GenericView data quality →
41.1Fair

ValueMarkers Composite Index

Top 6%#41,852 of 44,707
Overvalued

393% above intrinsic value ($5)

UndervaluedFair ValueOvervalued
Piotroski
5/9
Neutral
Beneish
-2.70
Low Risk
Altman
1.36
Distress
DCF Value
$5
Overvalued
ROIC
2.1%
Low
P/E
-
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

Elanco Animal Health Incorporated (ELAN) — VMCI valuation read

ELAN prints VMCI 41/100 inside the Healthcare sector, where the median sits at 50. The 9-point below-median delta is the cleanest single-number summary of Elanco Animal Health Incorporated's composite stance, and in the mid-cap bucket it places the share behind the typical peer on the five-pillar mix.

On ELAN, the SEC EDGAR Form 4 stream shows no insider buys or sells in the past 30 days. Quiet tapes happen; they just remove a signal that bull and bear cases sometimes lean on for confirmation.

**Investor frame.** ELAN trades at 24.0x earnings, 33% above the Healthcare median of 18.0x; that is the value line. ROIC of 14.0% sits 4.0pp above the Healthcare median (10.0%); that is the quality line. net debt to EBITDA of -1.2x leaves covenant headroom; that is the risk line for Elanco Animal Health Incorporated on the trailing financials.

ELAN rose 2.1% over the trailing 7 days, with a -23.2% read on a 30-day basis.

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

CEO: Jeffrey N. Simmons9,000 employeesUSwww.elanco.com

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in ELAN’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.